Genetic approaches to metabolic bone diseases

Area of Science:

• Endocrinology and Genetics
• Skeletal Biology
• Molecular Medicine

Background:

• Metabolic bone diseases disrupt skeletal homeostasis, often linked to abnormal calcium, phosphate, or vitamin D levels.
• These disorders frequently stem from genetic factors, ranging from single gene mutations (monogenic) to multiple gene variations (oligogenic/polygenic).
• Monogenic disorders caused by germline mutations typically exhibit high penetrance, while polygenic forms involve smaller effects influenced by environmental factors.

Purpose of the Study:

• To emphasize the clinical importance of recognizing familial monogenic metabolic bone diseases.
• To guide clinicians in the systematic diagnosis of these complex genetic disorders.
• To highlight the necessity of understanding molecular genetic testing for accurate diagnosis and management.

Main Methods:

• Comprehensive clinical evaluation, including detailed patient history and physical examination.
• Targeted laboratory investigations to assess mineral and vitamin D metabolite levels.
• Skeletal imaging studies to evaluate bone structure and abnormalities.
• Application of molecular genetic testing for identifying specific gene mutations.

Main Results:

• Identification of diverse genetic underpinnings for metabolic bone diseases, from monogenic to polygenic.
• Demonstration that germline mutations in single genes often lead to high-penetrance Mendelian diseases.
• Acknowledgement of environmental factors contributing to the smaller effects of genetic variations in oligogenic/polygenic disorders.

Conclusions:

• Early recognition of familial monogenic bone diseases is vital for timely patient and relative management.
• A systematic diagnostic approach combining clinical assessment, lab work, imaging, and genetic testing is essential.
• Understanding the expanding landscape of molecular genetic tests is crucial for their appropriate use and interpretation in diagnosing metabolic bone diseases.